Company name: | Astrazeneca Plc |
Company Description: | A group engaged in R&D; manufacture & marketing of prescription pharmaceuticals & biological products for healthcare areas such as cardiovascular; neuroscience; oncology; respiratory & inflammation
|
EPIC: | AZN | Trading Currency: | GBX |
Market Sector: | FE10 | ISIN: | GB0009895292 |
Market Segment: | SET1 | Share Type: | DE |
WWW Address: | http://www.astrazeneca.com/ | Description: | ORD SHS $0.25 |
Industry Sector: | PHARMACEUTICALS & BIOTECHNOLOGY |
Price | Price Change [%] | Bid | Ask | Open | High | Low | Volume |
7,897.00 | 120.0 [1.54] | 7,870.00 | 7,872.00 | 7,867.00 | 7,947.00 | 7,804.00 | 3,762,354 |
Market Cap. [m] | Shares In Issue [m] | Beta | EPS | DPS | PE Ratio | Yield | 52-Wks-Range |
103,601.11 | 1,311.90 | -0.96 | 75.31 | 211.13 | 104.86 | 2.67 | 10,120.00 - 5,871.00 |
Astrazeneca Key Figures
|
Astrazeneca Balance Sheet
 Share Price PerformanceSample Period † | High | Low | 1 week | 7,947.00 | 7,563.00 |
4 weeks | 7,947.00 | 7,269.00 |
12 weeks | 8,799.00 | 7,196.00 |
1 year | 10,120.00 | 5,871.00 |
 Share Price Chart (5 years)
|
Astrazeneca Historic ReturnsGiorni da oggi † | Open | Change | % | Open Avg. | Avg. Daily Vol [m] | Total Vol [m] | VWAP | 1 week | 7,588.00 | 309.00 | 4.07 | 7,563.00 | 2.53 | | 7,693.92 |
4 weeks | 7,509.00 | 388.00 | 5.17 | 7,269.00 | 2.83 | | 7,535.15 |
12 weeks | 7,827.00 | 70.00 | 0.89 | 7,196.00 | 2.73 | | 7,796.62 |
26 weeks | 8,655.00 | -758.00 | -8.76 | 7,196.00 | 2.11 | | 8,041.93 |
1 year | 7,550.00 | 347.00 | 4.60 | 5,871.00 | 2.39 | | 7,922.22 |
3 years | 4,963.00 | 2,934.00 | 59.12 | 4,544.50 | 2.24 | | 6,756.61 |
5 years | 4,379.00 | 3,518.00 | 80.34 | 3,680.00 | 2.43 | | 5,792.74 |
† periods calculated are whole weeks rather than calendar months | |
|
Astrazeneca Key Management Ratios
|
Astrazeneca Investment Ratios
|
Astrazeneca Financial Ratios
Beta (60-Mnth) | Beta (36-Mnth) | -0.9596 | -2.1555 |
|
Astrazeneca Operating Ratios
|
Astrazeneca DividendsAnnouncement Date | Type | Curr. | Dividend Amount | Period Start | Period End | Ex Date | Record Date | Payment Date | Total Dividend Amount | 14 Feb 2020 | Interim | USX | 190.00 | 12/31/2018 | 12/31/2019 | 02/27/2020 | 02/28/2020 | 03/30/2020 | 280.00 |
25 Jul 2019 | Interim | USX | 90.00 | 12/31/2018 | 12/31/2019 | 08/08/2019 | 08/09/2019 | 09/09/2019 | - |
14 Feb 2019 | Final | USX | 190.00 | 12/31/2017 | 12/31/2018 | 02/28/2019 | 03/01/2019 | 03/27/2019 | 280.00 |
26 Jul 2018 | Interim | USX | 90.00 | 12/31/2017 | 12/31/2018 | 08/09/2018 | 08/10/2018 | 09/10/2018 | - |
02 Feb 2018 | Final | USX | 190.00 | 12/31/2016 | 12/31/2017 | 02/15/2018 | 02/16/2018 | 03/19/2018 | 280.00 |
27 Jul 2017 | Interim | USX | 90.00 | 12/31/2016 | 12/31/2017 | 08/10/2017 | 08/11/2017 | 09/11/2017 | - |
02 Feb 2017 | Final | USX | 190.00 | 12/31/2015 | 12/31/2016 | 02/16/2017 | 02/17/2017 | 03/20/2017 | 280.00 |
28 Jul 2016 | Interim | USX | 90.00 | 12/31/2015 | 12/31/2016 | 08/11/2016 | 08/12/2016 | 09/12/2016 | - |
04 Feb 2016 | Final | USX | 190.00 | 12/31/2014 | 12/31/2015 | 02/18/2016 | 02/19/2016 | 03/21/2016 | 280.00 |
30 Jul 2015 | Interim | USX | 90.00 | 12/31/2014 | 12/31/2015 | 08/13/2015 | 08/14/2015 | 09/14/2015 | - |
05 Feb 2015 | Final | USX | 190.00 | 12/31/2013 | 12/31/2014 | 02/19/2015 | 02/20/2015 | 03/23/2015 | 280.00 |
31 Jul 2014 | Interim | USX | 90.00 | 12/31/2013 | 12/31/2014 | 08/13/2014 | 08/15/2014 | 09/15/2014 | - |
06 Feb 2014 | Final | USX | 190.00 | 12/31/2012 | 12/31/2013 | 02/19/2014 | 02/21/2014 | 03/24/2014 | 280.00 |
01 Aug 2013 | Interim | USX | 90.00 | 12/31/2012 | 12/31/2013 | 08/14/2013 | 08/16/2013 | 09/16/2013 | - |
31 Jan 2013 | Final | USX | 190.00 | 12/31/2011 | 12/31/2012 | 02/13/2013 | 02/15/2013 | 03/18/2013 | 280.00 |
26 Jul 2012 | Interim | USX | 90.00 | 12/31/2011 | 12/31/2012 | 08/08/2012 | 08/10/2012 | 09/10/2012 | - |
02 Feb 2012 | Final | USX | 195.00 | 12/31/2010 | 12/31/2011 | 02/15/2012 | 02/17/2012 | 03/19/2012 | 280.00 |
28 Jul 2011 | Interim | USX | 85.00 | 12/31/2010 | 12/31/2011 | 08/03/2011 | 08/05/2011 | 09/12/2011 | - |
27 Jan 2011 | Final | USX | 185.00 | 12/31/2009 | 12/31/2010 | 02/02/2011 | 02/04/2011 | 03/14/2011 | 255.00 |
29 Jul 2010 | Interim | USX | 70.00 | 12/31/2009 | 12/31/2010 | 08/02/2010 | 08/04/2010 | 09/13/2010 | - |
28 Jan 2010 | Final | USX | 171.00 | 12/31/2008 | 12/31/2009 | 02/03/2010 | 02/05/2010 | 03/15/2010 | 230.00 |
30 Jul 2009 | Interim | USX | 59.00 | 12/30/2008 | 06/30/2009 | 08/05/2009 | 08/07/2009 | 09/14/2009 | - |
29 Jan 2009 | Final | USX | 150.00 | 12/31/2007 | 12/31/2008 | 02/04/2009 | 02/06/2009 | 03/16/2009 | 205.00 |
31 Jul 2008 | Interim | USX | 55.00 | 12/30/2007 | 06/30/2008 | 08/08/2008 | 08/06/2008 | 09/15/2008 | - |
31 Jan 2008 | Final | USX | 135.00 | 12/31/2006 | 12/31/2007 | 02/06/2008 | 02/08/2008 | 03/17/2008 | 187.00 |
26 Jul 2007 | Interim | USX | 52.00 | 06/30/2006 | 06/30/2007 | 08/08/2007 | 08/10/2007 | 09/17/2007 | - |
01 Feb 2007 | Final | USX | 123.00 | 12/31/2005 | 12/31/2006 | 02/07/2007 | 02/09/2007 | 03/19/2007 | 172.00 |
27 Jul 2006 | Interim | USX | 49.00 | 12/30/2005 | 06/30/2006 | 08/09/2006 | 08/11/2006 | 09/18/2006 | - |
01 Feb 2006 | Final | USX | 92.00 | 12/31/2004 | 12/31/2005 | 02/08/2006 | 02/10/2006 | 03/20/2006 | 130.00 |
29 Jul 2005 | Interim | USX | 38.00 | 12/30/2004 | 06/30/2005 | 08/10/2005 | 08/12/2005 | 09/19/2005 | - |
27 Jan 2005 | Final | USX | 64.50 | 12/31/2003 | 12/31/2004 | 02/09/2005 | 02/11/2005 | 03/21/2005 | 94.00 |
22 Jul 2004 | Interim | USX | 29.50 | 12/30/2003 | 06/30/2004 | 08/11/2004 | 08/13/2004 | 09/20/2004 | - |
29 Jan 2004 | Final | USX | 54.00 | 12/31/2002 | 12/31/2003 | 02/18/2004 | 02/20/2004 | 04/06/2004 | 79.50 |
24 Jul 2003 | Interim | USX | 25.50 | 12/30/2002 | 06/30/2003 | 08/20/2003 | 08/22/2003 | 10/06/2003 | - |
30 Jan 2003 | Final | USX | 47.00 | 12/31/2001 | 12/31/2002 | 02/19/2003 | 02/21/2003 | 04/07/2003 | 70.00 |
25 Jul 2002 | Interim | USX | 23.00 | 12/30/2001 | 06/30/2002 | 08/21/2002 | 08/23/2002 | 10/07/2002 | - |
31 Jan 2002 | Final | USX | 47.00 | 12/31/2000 | 12/31/2001 | 02/20/2002 | 02/22/2002 | 04/08/2002 | 70.00 |
26 Jul 2001 | Interim | USX | 23.00 | 12/30/2000 | 06/30/2001 | 08/22/2001 | 08/24/2001 | 10/05/2001 | - |
08 Feb 2001 | Final | USX | 47.00 | 12/31/1999 | 12/31/2000 | 02/21/2001 | 02/23/2001 | 04/09/2001 | 70.00 |
01 Aug 2000 | Interim | USX | 23.00 | 12/30/1999 | 06/30/2000 | 09/04/2000 | 09/08/2000 | 10/23/2000 | - |
24 Feb 2000 | Final | USX | 47.00 | 12/31/1998 | 12/31/1999 | 03/06/2000 | 03/10/2000 | 04/17/2000 | 70.00 |
03 Aug 1999 | Interim | USX | 23.00 | 12/30/1998 | 06/30/1999 | 09/06/1999 | 09/10/1999 | 10/25/1999 | - |
|
|
Astrazeneca Fundamentals |
| 31 Dec 2016 (USD) | | 31 Dec 2017 (USD) | | 31 Dec 2018 (USD) | | 31 Dec 2019 (USD) | |
turnover | 23,002.00 | 100.00% |  | 22,465.00 | 100.00% |  | 22,090.00 | 100.00% |  | 24,384.00 | 100.00% | m |
pre tax profit | 3,552.00 | 15.44% |  | 2,227.00 | 9.91% |  | 1,993.00 | 9.02% |  | 1,548.00 | 6.35% | m |
attributable profit | 3,499.00 | 15.21% |  | 3,001.00 | 13.36% |  | 2,155.00 | 9.76% |  | 1,335.00 | 5.47% | m |
retained profit | -62.00 | -0.27% |  | -518.00 | -2.31% |  | -1,329.00 | -6.02% |  | -2,257.00 | -9.26% | m |
eps - basic | 277.00 | |  | 237.00 | |  | 170.00 | |  | 103.00 | |  |
eps - diluted | 277.00 | |  | 237.00 | |  | 170.00 | |  | 103.00 | |  |
dividends per share | 280.00 | |  | 280.00 | |  | 280.00 | |  | 280.00 | |  |
| | | | | | | | | | | | |
|
Astrazeneca Balance Sheet | 31 Dec 2016 (USD) | | 31 Dec 2017 (USD) | | 31 Dec 2018 (USD) | | 31 Dec 2019 (USD) | |
 |   |  |   |  |   |  |   |  |
|
| 31 Dec 2016 (USD) | | 31 Dec 2017 (USD) | | 31 Dec 2018 (USD) | | 31 Dec 2019 (USD) | |
ASSETS | | |  | | |  | | |  | | |  |
fixed assets | 6,848.00 | 10.95% |  | 7,615.00 | 12.02% |  | 7,421.00 | 12.24% |  | 7,688.00 | 12.53% | m |
intangibles | 39,244.00 | 62.76% |  | 38,013.00 | 60.00% |  | 33,666.00 | 55.51% |  | 33,148.00 | 54.01% | m |
fixed investments | 2,080.00 | 3.33% |  | 2,798.00 | 4.42% |  | 2,186.00 | 3.60% |  | 2,405.00 | 3.92% | m |
current assets - other | - | -% |  | - | -% |  | - | -% |  | 70.00 | 0.11% | m |
stocks | 2,334.00 | 3.73% |  | 3,035.00 | 4.79% |  | 2,890.00 | 4.76% |  | 3,193.00 | 5.20% | m |
debtors | 7,002.00 | 11.20% |  | 8,569.00 | 13.53% |  | 9,657.00 | 15.92% |  | 9,504.00 | 15.48% | m |
cash & securities | 5,018.00 | 8.03% |  | 3,324.00 | 5.25% |  | 4,831.00 | 7.97% |  | 5,369.00 | 8.75% | m |
 |
TOTAL | 62,526.00 | 100% |  | 63,354.00 | 100% |  | 60,651.00 | 100% |  | 61,377.00 | 100% | m |
|
LIABILITIES | | | | | | | | | | | | |
creditors - short | 15,256.00 | 24.40% |  | 16,383.00 | 25.86% |  | 16,292.00 | 26.86% |  | 18,117.00 | 29.52% | m |
creditors - long | 30,601.00 | 48.94% |  | 30,329.00 | 47.87% |  | 30,315.00 | 49.98% |  | 28,664.00 | 46.70% | m |
creditors - other | - | -% |  | - | -% |  | - | -% |  | - | -% | m |
subordinated loans | - | -% |  | - | -% |  | - | -% |  | - | -% | m |
insurance funds | - | -% |  | - | -% |  | - | -% |  | - | -% | m |
|
TOTAL | 45,857.00 | 73.34% |  | 46,712.00 | 73.73% |  | 46,607.00 | 76.84% |  | 46,781.00 | 76.22% | m |
|
EQUITY | | | | | | | | | | | | |
ord cap, reserves | 14,854.00 | 23.76% |  | 14,960.00 | 23.61% |  | 12,468.00 | 20.56% |  | 13,127.00 | 21.39% | m |
prefs, minorities | 1,815.00 | 2.90% |  | 1,682.00 | 2.65% |  | 1,576.00 | 2.60% |  | 1,469.00 | 2.39% | m |
|
TOTAL | 16,669.00 | 26.66% |  | 16,642.00 | 26.27% |  | 14,044.00 | 23.16% |  | 14,596.00 | 23.78% | m |
|
OTHER | | | | | | | | | | | | |
NAV Basic | - | |  | - | |  | - | |  | - | |  |
NAV Diluted | - | |  | - | |  | - | |  | - | |  |
|
Astrazeneca Cash Flow Statement | 31 Dec 2016 (USD) | | 31 Dec 2017 (USD) | | 31 Dec 2018 (USD) | | 31 Dec 2019 (USD) | |
Operating CF | 4,145.00 | | 3,578.00 | | 2,618.00 | | 2,969.00 | m |
Pre-Financing CF | 176.00 | | 1,250.00 | | 3,581.00 | | 2,312.00 | m |
Retained CF | -1,148.00 | | -1,686.00 | | 1,537.00 | | 547.00 | m |
| | | | | | | | |
| Astrazeneca Brokers
| | | | |
|
|
|